$AUPH
Aurinia Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
$15.83
▼-0.75%-$0.120
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAurinia Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is AUPH down today? It is at $15.83 (-0.75%), and our scanner flagged it 51 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AUPH spikes, and full due diligence on AUPH — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AUPH 51 times in the last 30 days. Create a free account to track $AUPH, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on AUPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AUPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAurinia Settles Patent Litigation with Teva, from an SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Robertson Stephen P. Officer | Sold (automatic/other) | -12K | sold 2.0% | 589K | $190K at $15.95 | Sep 10, 26 |
Robertson Stephen P. Officer | Sold (automatic/other) | -21K 0.02% of company | sold 3.4% | 601K | $356K at $16.97 | Aug 21, 26 |
Tang Kevin Officer | Bought (open market) | +206K 0.2% of company | added 1.6% | 13.04M | $3.1M at $15.28 | Jun 2, 26 |
Tang Kevin Officer | Bought (open market) | +344K 0.3% of company | added 2.8% | 12.84M | $5.3M at $15.28 | Jun 1, 26 |
Tang Kevin Officer | Bought (open market) | +265K 0.2% of company | added 2.2% | 12.49M | $4.1M at $15.31 | May 29, 26 |
Cole Ryan Officer | Acquired (grant/award) | +116K 0.09% of company | n/a | 116K | n/a | May 18, 26 |
Hearne Michael S Officer | Acquired (grant/award) | +116K 0.09% of company | n/a | 116K | n/a | May 18, 26 |
Robertson Stephen P. Officer | Acquired (grant/award) | +116K 0.09% of company | added 23% | 621K | n/a | May 18, 26 |
Keenan Greg Officer | Sold (automatic/other) | -8K | sold 5.0% | 154K | $116K at $14.32 | Mar 6, 26 |
Tang Kevin Director | Bought (open market) | +184K 0.1% of company | added 1.5% | 12.23M | $2.6M at $14.22 | Mar 3, 26 |
Greenleaf Peter Officer | Sold (automatic/other) | -101K 0.08% of company | sold 5.2% | 1.84M | $1.4M at $14.21 | Mar 2, 26 |
Miller Joseph M Officer | Sold (automatic/other) | -38K 0.03% of company | sold 6.1% | 576K | $533K at $14.21 | Mar 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on AUPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for AUPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
AUPH last traded at $15.83, down 0.75% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Aurinia Pharmaceuticals Inc (AUPH) is next expected to report earnings on Tuesday, November 3, 2026, about 30 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The AUPH Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AUPH 51 times in the last 30 days.
AUPH (Aurinia Pharmaceuticals Inc) trades on XNAS, with a market cap of about $2.11B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AUPH for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$AUPH discussion
Sign in to ask a question or join the discussion.